Dr Phillip Frost image

Teva chairman stepping down amid revamp

June 19, 2014
Manufacturing and Production, Medical Communications, Sales and Marketing Frost, Levin, Teva, chief, generics, israel, pharma

Having just announced closing half of its manufacturing sites Teva has now confirmed that chairman Dr Phillip Frost is to …

Valeant image

Valeant goes hostile over Allergan hunt

June 19, 2014
Sales and Marketing Allergan, Botox, Valeant, hostile, takeover

Valeant Pharmaceuticals has turned hostile in its bid to acquire Botox maker Allergan by employing strong-arm tactics in an attempt …

Dementia image

£16m dementia research platform launched

June 19, 2014
Research and Development, Sales and Marketing Alzheimer's, MRC, Parkinson's, brain, dementia, ukdp

The Medical Research Council (MRC) has launched the UK Dementias Research Platform (UKDP), a £16 million public-private partnership set up …

dominique_pizzingrilli

Bartlett hires account manager

June 19, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dominique Pizzingrilli, bartlett Davis Communications

Bartlett Davis Communications has welcomed Dominique Pizzingrilli to the newly-created role of account manager. Pizzingrilli takes a wealth of healthcare …

Abbvie image

AbbVie hep C treatment fast-tracked

June 18, 2014
Research and Development, Sales and Marketing AbbVie, Abbott, EMA, EU, Gilead, HCV, hep C, sovaldi

The European regulator is to fast-track AbbVie’s oral, interferon-free treatment for adults with chronic genotype 1 (GT1) hepatitis C virus …

Social media image

FDA publishes ‘new thinking’ on social media use

June 18, 2014
Medical Communications, Sales and Marketing ABPI, FDA, Facebook, Twitter, social media

The FDA has issued new draft guidance on how pharmaceutical and medical device firms in the US can talk about …

Genome-driven lung cancer trial launches

June 18, 2014
Research and Development, Sales and Marketing AstraZeneca, Cancer, Genentech, MedImmune, Pfizer, genome, lung cancer

Amgen, Genentech, Pfizer, AstraZeneca and MedImmune – AstraZeneca’s global biologics R&D arm – have each put investigative treatments into a …

david_meline_amgen_

Amgen lures senior head from 3M

June 18, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing amgen 3m, david meline

Amgen has poached David Meline from US multinational firm 3M to serve as an executive VP and chief financial officer. …

Teva image

Teva to close half its sites

June 17, 2014
Manufacturing and Production, Sales and Marketing Jobs, Teva, cuts, generics, manufacturing

Teva Pharmaceutical Industries is to close around half of its 75 manufacturing sites within the next five years, chief financial …

jonathan_emms_close

ABPI president: NICE needs political reform

June 17, 2014
Business Services, Medical Communications, Research and Development ABPI, NHS, NICE, Pfizer, QALY, emms, jonathan, vba

NICE needs to be reformed with its QALY formula heavily revised if it is to meet the challenges of 21st …

Pfizer opens R&D hub in US Cambridge

June 17, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Cambridge, Massachusetts, Pfizer, kit, manufacturing, research

Pfizer has open a new 280,000 sq.ft. R&D hub in Cambridge, Massachusetts which also serves to bring together 1,000 of …

Professor Colin Blakemore image

Knighthoods for Blakemore and Francis

June 17, 2014
Medical Communications, Sales and Marketing Francis, Mid Staffs, NHS, blakemore, mdc, queen

Two key figures in healthcare research and reform received knighthoods in the Queen’s Birthday Honours. Professor Colin Blakemore, former head …

screen_shot_2014-06-17_at_07

John Handley appointed chairman of Fishawack

June 17, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing fishawack, handley

The Fishawack Group has appointed John Handley to fulfill the role of chairman for the UK medical comms specialists. Handley …

EMA image

EMA changes ‘on screen’ data policy

June 16, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, EMA, Goldacre, Humira, alltrials, transparency

The European Medicines Agency is to formally agree its policy on the vexed issue of the publication of clinical trial …

gilead_-sciences

NICE rejection looms for Sovaldi

June 16, 2014
Sales and Marketing Gilead, NHS, NICE, SMC, hep C, sofosbuvir, sovaldi

In a draft recommendation published today NICE is asking Gilead for more information on its new hepatitis C pill Sovaldi …

screen_shot_2014-06-16_at_09

Avillion hires Lundbeck chief executive

June 16, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Avillion, Lundbeck, wiinberg

UK drug development firm Avillion has appointed Lundbeck chief executive Ulf Wiinberg as the chairman of its board of directors. …

Medtronic image

Sanofi and Medtronic partner on diabetes

June 16, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, diabetes, medtronic

Sanofi and Medtronic have announced a new tie-up that will see both firms develop new products in the increasingly competitive …

US focus: still top of the pharma pile

June 16, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medicare, Obama, Sunshine Act, US, United States, america, report

Population: 313.9 million (2012) Government: Federal presidential republic Leader: President Barack Obama of the liberal Democratic Party Gross Domestic Product: …

Biotec chief executive appointed to government advisory panel





June 16, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biotec, wither

The chief executive of Biotec Services International Dr Fiona Withey has been appointed to
provide guidance to the Welsh government on …

Pharmaxis image

PMCPA raps Pharmaxis

June 16, 2014
Manufacturing and Production, Sales and Marketing ABPI, CML, PMCPA, pharmaxis

Pharmaxis Pharmaceuticals has been given the most severe punishment that the PMCPA can hand out following a series of breaches …

The Gateway to Local Adoption Series

Latest content